Vaughan David Investments LLC Astrazeneca PLC Transaction History
Vaughan David Investments LLC
- $4.64 Billion
- Q3 2025
A detailed history of Vaughan David Investments LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Vaughan David Investments LLC holds 509,980 shares of AZN stock, worth $45.6 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
509,980
Previous 504,915
1.0%
Holding current value
$45.6 Million
Previous $35.3 Million
10.89%
% of portfolio
0.84%
Previous 0.79%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,554Shares Held
503MCall Options Held
5.54MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...